Clinical Outcomes of Off-pump Coronary Artery Bypass Grafting

심폐바이패스 없는 관상동맥우회술의 임상성적

  • Shin, Je-Kyoun (Department of Thoracic and Cardiovascular Surgery, Ulsan University Hospital, University of Ulsan College of Medicine) ;
  • Kim, Jeong-Won (Department of Thoracic and Cardiovascular Surgery, Ulsan University Hospital, University of Ulsan College of Medicine) ;
  • Jung, Jong-Pil (Department of Thoracic and Cardiovascular Surgery, Ulsan University Hospital, University of Ulsan College of Medicine) ;
  • Park, Chang-Ryul (Department of Thoracic and Cardiovascular Surgery, Ulsan University Hospital, University of Ulsan College of Medicine) ;
  • Park, Soon-Eun (Department of Anesthesiology and Pain Medicine, Ulsan University Hospital, University of Ulsan College of Medicine)
  • 신제균 (울산대학교 의과대학 울산대학교병원 흉부외과학교실) ;
  • 김정원 (울산대학교 의과대학 울산대학교병원 흉부외과학교실) ;
  • 정종필 (울산대학교 의과대학 울산대학교병원 흉부외과학교실) ;
  • 박창률 (울산대학교 의과대학 울산대학교병원 흉부외과학교실) ;
  • 박순은 (울산대학교 의과대학 울산대학교병원 마취통증의학교실)
  • Published : 2008.02.05

Abstract

Background: Off-pump coronary artery bypass grafting (OPCAB) shows fewer side effects than cardiopulmonary by. pass, and other benefits include myocardial protection, pulmonary and renal protection, coagulation, inflammation, and cognitive function. We analyzed the clinical results of our cases of OPCAB. Material and Method: From May 1999 to August 2007, OPCAB was performed in 100 patients out of a total of 310 coronary artery bypass surgeries. There were 63 males and 37 females, from 29 to 82 years old, with a mean age of $62{\pm}10$ years. The preoperative diagnoses were unstable angina in 77 cases, stable angina in 16, and acute myocardial infarction in 7. The associated diseases were hypertension in 48 cases, diabetes in 42, chronic renal failure in 10, carotid artery disease in 6, and chronic obstructive pulmonary disease in 5. The preoperative cardiac ejection fraction ranged from 26% to 74% (mean $56.7{\pm}11.6%$). Preoperative angiograms showed three-vessel disease in 47 cases, two-vessel disease in 25, one-vessel disease in 24, and left main disease in 23. The internal thoracic artery was harvested by the pedicled technique through a median sternotomy in 97 cases. The radial artery and greater saphenous vein were harvested in 70 and 45 cases, respectively (endoscopic harvest in 53 and 41 cases, respectively). Result: The mean number of grafts was $2.7{\pm}1.2$ per patient, with grafts sourced from the unilateral internal thoracic artery in 95 (95%) cases, the radial artery in 62, the greater saphenous vein in 39, and the bilateral internal thoracic artery in 2. Sequential anastomoses were performed in 46 cases. The anastomosed vessels were the left anterior descending artery in 97 cases, the obtuse marginal branch in 63, the diagonal branch in 53, the right coronary artery in 30, the intermediate branch in 11, the posterior descending artery in 9 and the posterior lateral branch in 3. The conversion to cardiopulmonary bypass occurred in 4 cases. Graft patency was checked before discharge by coronary angiography or multi-slice coronary CT angiography in 72 cases, with a patency rate of 92.9% (184/198). There was one case of mortality due to sepsis. Postoperative arrhythmias or myocardial in-farctions were not observed. Postoperative complications were a cerebral stroke in 1 case and wound infection in 1. The mean time of respirator care was $20{\pm}35$ hours and the mean duration of stay in the intensive care unit was $68{\pm}47$ hours. The mean amounts of blood transfusion were $4.0{\pm}2.6$ packs/patient. Conclusion: We found good clinical outcomes after OPCAB, and suggest that OPCAB could be used to expand the use of coronary artery bypass grafting.

배경: 심폐바이패스 없는 관상동맥우회술의 개발은 심폐바이패스로 일어나는 부작용을 피함으로써 관상동맥우회술의 적용범위를 더 확대할 수 있게 하였다. 특히 심폐바이페스 없는 관상동맥우회술은 심근보호 폐 및 신기능의 보호, 혈액응고 장애 예방, 전신 염증 반응 및 인지기능의 예방 등에서 이점이 있는 것으로 알려져 있다. 저자들은 관상동맥우회수술을 좀 더 작대 적용할 수 있는지를 알기 위하여 심폐바이패스 없는 관상동맥우회술의 임상성적을 분석하였다. 대상 및 방법: 1999년 5월부터 2007년 8월까지 관상동맥우회술을 시행한 310예의 한자 중 심폐바이패스 없이 시행한 100명을 대상으로 하였다. 남자가 63명, 여자가 37명이었으며 평균연령은 $62{\pm}10$세($29{\sim}82$세)이었다. 수술 전 진단은 불안정성 협심증이 77예, 안정성 협심증이 16예이었으며 급성심근경색증인 경우가 7예이었다. 동반된 질병은 고혈압이 48예, 당뇨병 42예, 신부전증의 경우가 10예이었고 만성폐쇄성폐질환이 5예, 경동맥질환이 동반된 경우가 6예이었다. 수슬 전 평균 심박출률은 $56.7{\pm}11.6%$ ($26{\sim}74%$)였다. 관상동맥조영술에서 심혈관질환이 47예, 이혈관질환이 25예이었고 단일혈관질환이 24예였으며, 이 중 좌주관상동맥협착이 있는 경우가 23예이었다. 내흉동맥은 97예에서 경상이식편으로 획득하였고 요골동맥과 대복재정맥은 각각 70예, 45예이었으며 이 중 내시경을 사용한 혈관 확보는 각각 53예, 41예 이었다. 결과: 평균 $2.7{\pm}1.2$개의 문합을 하였다. 일측 내흉동맥은 95예(95%)에서 사용되었으며 요골동맥이 62예, 대복재정맥이 39예였고 양측 내흉동맥은 2예에서 시행되었으며, 100예 중 연속문합은 46예가 있었다. 각각의 관상동맥별 문합 수는 좌전하행지가 97개소, 둔각변연지가 63개소, 대각지가 53개소, 우관상동맥이 30개소, 중간분지가 11개소, 후하행동맥이 9개소, 그리고 후측방분지가 3개소였다. 수술 중 심폐바이패스로 전환한 경우는 4예 있었다. 전체 100예 중 72예에서 퇴원 전 관상동맥조영술 혹은 다중절편 컴퓨터 단층촬영술을 이용한 관상동맥영상술로 확인하였는데 198문합 중에 184문합(92.9%)에서 개통성이 유지되었다. 수술 후 1예에서 패혈증으로 사망하였으며, 뇌경색 1예와 창상 감염 1예가 있었고 술 후 부정맥과 심근경색증은 없었다. 수술 후 평균 인공호흡기보조시간은 $20{\pm}35$시간이었으며 중환자실 체류시간은 $68{\pm}47$시간이었다. 수술 중 평균 수혈양은 $4.0{\pm}2.6\;pack$이었다. 결론: 저자들은 100예의 심폐바이패스 없는 관상동맥우회술을 시행하여 좋은 성적을 얻었기에 관상동맥우회수술의 범위를 확대하기 위해 사용할 수 있는 수술이라 제시할 수 있겠다.

Keywords

References

  1. Hill RA, Dundar Y, Bakhai A, et al. Drug-eluting stents: an early systematic review to inform policy. Eur Heart J 2004;25:902-19 https://doi.org/10.1016/j.ehj.2004.03.023
  2. Briguori C, Colombo A, Airoldi F, et al. Sirolimus-eluting stent implantation in diabetic patients with multivessel coronary artery disease. Am Heart J 2005;150:807-13 https://doi.org/10.1016/j.ahj.2004.12.012
  3. Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006;48:193-202 https://doi.org/10.1016/j.jacc.2006.03.042
  4. US Food and Drug Administration Public Health Web Notification. FDA statement on coronary drug-eluting stents. 2006. Available at: http://www.fda.gov/cdrh/news/ 091406. html. Accessed November 3, 2006
  5. Feldman T. Increased mortality with DES: is this a real issue? December, 2006. http://www.cardiosource.com Accessed October 10, 2007
  6. Sabik JF, Gillinov AM, Blackstone EH, et al. Does off- pump coronary surgery reduce morbidity and mortality? J Thorac Cardiovasc Surg 2002;124:698-707 https://doi.org/10.1067/mtc.2002.121975
  7. Clevel JC, Shroyer AL, Chen AY, et al. Off-pump coronary artery bypass grafting decreases risk-adjusted mortality and morbidity. Ann Thorac Surg 2001;72:1282-8 https://doi.org/10.1016/S0003-4975(01)03006-5
  8. Plomondon ME, Cleveland JC, Ludwig ST, et al. Off-pump coronary artery bypass is associated with improved risk-adjusted outcomes. Ann Thorac Surg 2001;72:114-9 https://doi.org/10.1016/S0003-4975(01)02670-4
  9. Legare JF, Buth KJ, King S, et al. Coronary bypass surgery performed off pump does not result in lower in-hospital morbidity than coronary artery bypass grafting performed on pump. Circulation 2004;109:887-92 https://doi.org/10.1161/01.CIR.0000115943.41814.7D
  10. Karolak W, Hirsch G, Buth K, et al. Medium-term outcomes of coronary bypass graft surgery on pump versus off pump: results from a randomized controlled trial. Am Heart J 2007;153:689-95 https://doi.org/10.1016/j.ahj.2007.01.033
  11. Takai H, Tanabashi T, Kawai N, et al. Off-pump coronary artery bypass graf patency: meta-analysis of randomized trials. J Thorac Cardiovasc Surg 2007;133:2-3 https://doi.org/10.1016/j.jtcvs.2003.03.006
  12. Gardner TJ. On-pump versus off-pump coronary artery bypass grafting. J Thorac Cardiovasc Surg 2007;133:1 https://doi.org/10.1016/j.jtcvs.2006.09.006
  13. Song HK, Puskas JD. Off-pump coronary artery bypass surgery. In: Kaiser LR, Kron IL, Spray TL. Mastery of cardiothoracic surgery. 2nd ed. Philadelphia: Lippincott Williams & Wilkins. 2007:454-5
  14. Paparella D, Cappabianca G, Malvindi P, at al. Myocardial injury after off-pump coronary artery bypass grafting operation. Eur J Cardiothorac Surg 2007;32:481-9 https://doi.org/10.1016/j.ejcts.2007.06.015
  15. Nageh T, Sherwood RA, Harris BM, Byrne JA, Thomas MR. Cardiac troponin T and I and creatine kinase-MB as markers of myocardial injury and predictors of outcome following precutaneous coronary intervention. Int J Cardiol 2003;92:285-93 https://doi.org/10.1016/S0167-5273(03)00105-0
  16. Mussa S, Choudhary BP, Taggart DP. Radial artery conduits for coronary artery bypass grafting current perspective. J Thorac Cardiovasc Surg 2005;129:250-3 https://doi.org/10.1016/j.jtcvs.2004.07.040
  17. Bleiziffer S, Hettich I, Eisenhauer B, et al. Patency rates of endoscopically harvested radial arteries one year after coronary artery bypass grafting. J Thorac Cardiovasc Surg 2007;134:649-56 https://doi.org/10.1016/j.jtcvs.2007.04.008